Bedrijfsvoering Pfizer Inc.

PFE

US7170811035

Farmaceutische producten

Beurs gesloten - Nyse Andere beurzen 22:00:02 12-12-2025			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
25,85 ^USD	+0,19%		-0,69%	-2,56%

12/12	Amerikaanse FDA keurt oraal antibioticum van Innoviva voor gonorroe goed	RE
12/12	Pfizer Inc. kondigt dividend voor het eerste kwartaal van 2026 aan, betaalbaar op 6 maart 2026	CI

Uitvoerend comité: Pfizer Inc.

Bedrijfsleider

Beklede functiesVan

Albert Bourla

63 jaar

Chief Executive Officer

01-01-2019

Annaliesa Anderson

Chief Tech/Sci/R&D Officer

01-01-2007

Maria Rivas

61 jaar

Chief Tech/Sci/R&D Officer

01-09-2022

Chris Boshoff

Chief Tech/Sci/R&D Officer

01-01-2025

Susan Rienow

46 jaar

Sales & Marketing

01-07-2024

James F List

Chief Tech/Sci/R&D Officer

06-03-2025

David Denton

60 jaar

Director of Finance/CFO

02-05-2022

Rady Johnson

64 jaar

Compliance Officer

01-12-2013

Douglas Lankler

59 jaar

General Counsel

01-12-2013

Margaret M. Madden

General Counsel	-
Corporate Secretary	-

Lidia Fonseca

56 jaar

Chief Tech/Sci/R&D Officer

Jennifer Damico

57 jaar

Comptroller/Controller/Auditor

01-03-2020

Gordon Loh

Comptroller/Controller/Auditor

01-03-2020

Payal Sahni Becher

Human Resources Officer

01-01-1997

Patrizia A. Cavazzoni

Chief Tech/Sci/R&D Officer

24-02-2025

Samenstelling van de raad van bestuur: Pfizer Inc.

Directeur

RadenVan

Albert Bourla

63 jaar

Executive Committee Chair

01-01-2020

Joseph Echevarria

68 jaar

Audit Committee	25-06-2015
Executive Committee	25-06-2015
Governance Committee Chair	25-06-2015
Finance Committee
Governance Committee	01-04-2016

Ronald Blaylock

65 jaar

Compensation Committee	23-02-2017
Governance Committee	01-01-2001
Nominating Committee	01-01-2001
Audit Committee	23-02-2017

Scott Gottlieb

53 jaar

Executive Committee
Governance Committee	29-10-2019
Nominating Committee	29-10-2019

Tim Buckley

Audit Committee	15-10-2024
Governance Committee	01-01-2025
Finance Committee	01-01-2025

Cyrus Taraporevala

59 jaar

Audit Committee	27-06-2024
Compensation Committee	27-06-2024
Nominating Committee	14-12-2023

Suzanne Johnson

67 jaar

Executive Committee	01-09-2007
Audit Committee Chair	01-09-2007
Audit Committee	20-01-2022

Jim Smith

65 jaar

Audit Committee	26-06-2014
Executive Committee	26-06-2014
Compensation Committee Chair	26-06-2014

James Quincey

60 jaar

Executive Committee Chair	24-04-2019
Compensation Committee	27-02-2020

Sue Desmond-Hellmann

67 jaar

Governance Committee

01-01-2020

Shantanu Narayen

61 jaar

Executive Committee

27-09-2013

Dan Littman

72 jaar

Governance Committee

05-03-2018

Susan Hockfield

74 jaar

Director/Board Member	04-03-2020
Independent Dir/Board Member	04-03-2020

Recente benoemingen: Pfizer Inc.

10/12	Elevance Health benoemt Amy Schulman tot onafhankelijk bestuurder per 12 januari 2026	CI
10/12	Nuvalent, Inc. kondigt wijzigingen in Raad van Bestuur aan	CI
25/11	Novo Nordisk: geen rustig vaarwater
18/11	Scott Gottlieb treedt toe tot Raad van Bestuur UnitedHealth Group per 18 november 2025	CI
18/11	UnitedHealth benoemt voormalig FDA-topman Scott Gottlieb tot bestuurslid	RE
14/11	Voormalig Pfizer R&D-topman Dolsten trekt zich terug uit bestuursrace Novo Nordisk	RE
13/11	Novo Nordisk A/S: Mikael Dolsten stelt zich niet kandidaat voor Raad van Bestuur	CI

Meer nieuws

Voormalige zaakvoerders en bestuurders: Pfizer Inc.

Insider

Beklede functies

VanTot

Frank D'Amelio

Director of Finance/CFO	01-09-2007	01-06-2020
Corporate Officer/Principal	01-06-2020	01-12-2021

James Kilts

Director/Board Member	01-09-2007	16-11-2020
Independent Dir/Board Member	01-09-2007	16-11-2020

Wyllie Cornwell

Director/Board Member	01-02-1997	16-11-2020
Independent Dir/Board Member	01-02-1997	16-11-2020

Loretta V. Cangialosi

Comptroller/Controller/Auditor

01-03-2020

Dennis Ausiello

Director/Board Member	01-12-2006	25-04-2019
Chairman	25-05-2011	25-05-2011
Independent Dir/Board Member	23-04-2015	25-04-2019

George A. Lorch

Director/Board Member	01-06-2000	23-04-2015
Chairman	14-12-2010	13-12-2011
Independent Dir/Board Member	05-04-2011	23-04-2015

M. Anthony Burns

Director/Board Member	01-01-1988	19-12-2013
Independent Dir/Board Member	24-05-2011	19-12-2013

William Herbert Gray

Director/Board Member	01-06-2000	01-07-2013
Independent Dir/Board Member	24-05-2011	01-07-2013

Michael Brown

Director/Board Member	01-01-1996	01-04-2012
Independent Dir/Board Member	24-05-2011	01-04-2012

Briggs Morrison

Chief Tech/Sci/R&D Officer

01-10-2007

01-12-2011

Neil Gibson

Corporate Officer/Principal

01-01-2007

01-01-2011

Jeffrey Kindler

Director/Board Member	01-03-2005	31-07-2006
Chief Executive Officer	31-07-2006	05-12-2010
Chairman	19-12-2006	05-12-2010
General Counsel	01-01-2002	31-07-2006
Corporate Officer/Principal	01-01-2002	01-03-2005

Richard Bagger

Public Communications Contact

01-01-2006

01-01-2010

John LaMattina

Chief Tech/Sci/R&D Officer	01-01-1977	01-12-2008
Corporate Officer/Principal	01-01-1993	01-12-2008

Allen Waxman

General Counsel

01-01-2003

11-03-2008

David Shedlarz

Director/Board Member	01-07-2005	01-12-2007
Director of Finance/CFO	01-01-1999	01-07-2005
Corporate Officer/Principal	01-07-2005	01-12-2007

Alan Levin

Director of Finance/CFO	01-01-1987	01-09-2007
Treasurer	01-01-1987	01-09-2007

Ruth Simmons

Director/Board Member

01-01-1997

26-04-2007

Stanley O. Ikenberry

Director/Board Member

01-10-2005

22-03-2007

Karen Katen

Director/Board Member

01-01-1974

01-01-2007

Eliot Forster

Corporate Officer/Principal

01-01-1996

01-01-2007

Sharon Real

Corporate Officer/Principal

01-01-2000

01-01-2006

Jean-Paul Vallès

Director/Board Member

01-01-1980

23-06-2005

Yvonne R. Jackson

Human Resources Officer

01-07-2002

01-06-2005

Franklin Raines

Director/Board Member	01-10-1998	28-04-2005
Director/Board Member	01-01-1993	01-01-1996

Yoshihiro Toyohara

Corporate Officer/Principal

01-01-2003

01-01-2005

Brian Goldberg

Corporate Officer/Principal

01-06-2002

30-09-2004

William J. Creelman

Comptroller/Controller/Auditor

01-01-2003

01-01-2004

Lynne E. Weissberger

Director/Board Member

01-04-1996

01-12-2003

William H. D. Horton

Public Communications Contact

01-07-2002

01-09-2003

Pat Parr

Corporate Officer/Principal

01-01-1997

01-04-2003

George Milne

Director/Board Member	01-01-1984	01-01-1985
Chief Tech/Sci/R&D Officer	01-01-1970	01-01-2002

Warren R. Winter

Chief Tech/Sci/R&D Officer

01-01-1986

31-12-2001

Emmett Cunningham

Corporate Officer/Principal

31-12-2001

Wendell Wierenga

Corporate Officer/Principal

01-01-1990

01-07-2000

Michael Berendt

Corporate Officer/Principal

01-01-1982

01-01-2000

Richard G. Minicus

Corporate Officer/Principal

30-12-1998

John T. Boris

Corporate Officer/Principal

02-01-1988

01-01-1998

Dilip J. Mehta

Corporate Officer/Principal

01-01-1982

Mark A. Braman

Corporate Officer/Principal

01-01-1984

01-01-1996

Jonathan R. McGrath

Chief Tech/Sci/R&D Officer

01-01-1990

01-01-1995

Henrik Rasmussen

Corporate Officer/Principal

01-01-1989

01-12-1994

Robert Cohen

Corporate Officer/Principal

01-01-1981

01-01-1992

Gene Clapp

Corporate Officer/Principal

31-12-1987

Sylvia Montero

Human Resources Officer

01-01-1978

Robert H. Driver

Corporate Officer/Principal

Albert Michael Davis

Corporate Officer/Principal

Malcolm Kahn

Comptroller/Controller/Auditor	-	-
Sales & Marketing	-	-

Andrew McDonald

Corporate Officer/Principal

Jean-Michel Hotton

Corporate Officer/Principal

Richard A. Lotti

Corporate Officer/Principal

John Nicastro

Sales & Marketing

Robert W. Norton

Corporate Officer/Principal

John W. Mitchell

Corporate Officer/Principal

Shreya Prudlo

Public Communications Contact

Ali Shirazi

Corporate Officer/Principal

Gabriela G. Cezar

Corporate Officer/Principal

Daniel Cushing

Corporate Officer/Principal

Theodore Matthew Thome

Corporate Officer/Principal

Leonard C. Stephens

Human Resources Officer

James W. Larson

Human Resources Officer

Mike E. Pape

Corporate Officer/Principal

Jay Lichter

Corporate Officer/Principal

Tyana Kurtz

Sales & Marketing

Anup Arora

Corporate Officer/Principal

Peter Rost

Corporate Officer/Principal

Howard Zauberman

Corporate Officer/Principal

Steve Kennedy

Corporate Officer/Principal

David McGibney

Corporate Officer/Principal

Nancy Ramamurthi

Corporate Officer/Principal

Donald R. Sellers

Corporate Officer/Principal

Dennis J. Block

Corporate Officer/Principal

Andrew Hertzmark

Corporate Officer/Principal

Raul E. Kohan

Comptroller/Controller/Auditor

Robert L. Mallett

Public Communications Contact

Alan Lang

Corporate Officer/Principal

Michael Petrarca

Corporate Officer/Principal

Stephen Arneric

Corporate Officer/Principal

Pierre E. G. Etienne

Chief Operating Officer

Charles L. Hardwick

Public Communications Contact

01-01-1966

Leeftijdsdistributie van bedrijfsleiders

Ratio vrouwen/mannen

Man	34
Vrouw	9

Waarvan leden van het uitvoerend comité

Man	10
Vrouw	5

Waarvan bestuurders

Man	12
Vrouw	1

Herzieningen

Révisions CA 1 an

Révisions CA 4 mois

Révisions CA 1 mois

Révisions BNA 1 an

Révisions BNA 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Nee

Controverses sur les droits de l'Homme

Nee

Controverses Subventions fiscales

Nee

Conforme à la finance Islamique

Pfizer, Inc. is wereldwijd het grootste farmaceutische concern. De omzet per productfamilie wordt als volgt onderverdeeld: - producten voor eerstelijnszorg (47,4%): geneesmiddelen voor interne geneeskunde, vaccins, geneesmiddelen voor de preventie en behandeling van Covid-19, antivirale middelen, producten op basis van mRNA, enz.; - gespecialiseerde verzorgingsproducten (26,2%): geneesmiddelen gebruikt in immunologie, in ziekenhuizen en voor de behandeling van zeldzame ziekten, ontstekingsremmers, enz.; - oncologieproducten (24,5%); - andere (1,9%). 60,8% van de omzet wordt in de Verenigde Staten gegenereerd.

Werknemers

81.000

Sector

Farmaceutische producten

Agenda

16/12 - Q4 2026 Vooruitzichten van het bedrijf

Meer informatie over het bedrijf